Chemours (NYSE: CC) reported Q2 EPS of ($0.10), which may not compare with the analyst estimate of $0.41. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.53 billion.

For earnings history and earnings-related data on Chemours (CC) click here.